Remdesivir used to treat COVID patient in Banke district
Nepalgunj, September 2
Nepalgunj Medical College Teaching Hospital, Kohalpur, has used Remdesivir to treat a coronavirus infected patient for the first time in west Nepal in Banke from today. The medicine is being used on a patient with serious symptoms of COVID.
According to the hospital, the medicine was used on patients whose condition did not improve with other techniques.
The anti-viral medicine has been used on a 48-year-old male COVID infected person from Bishalnagar, Dhangadi, who is currently in Kohalpur.
He was admitted to the hospital on Monday.
Dr Shyam Bishwokarma has been leading this type of treatment. He said that the new technique might have a good effect on patients.
Dr Bishwokarma added that the medicine would stop coronavirus from increasing in the body. “Remdesivir will be given to patients with serious symptoms of the COVID for five days,” he informed.
Dr Bishwokarma said that the medicine would be given to patients, who had been in the ventilator for ten days.
“The medicine is more reliable in the world for treating COVID patients,” he said.
Statistics showed that the mortality rate was lower after the medicine was used.
Also physician at the hospital, Dr Bishwokarma said that Remdesivir would be used for treating COVID patients who were in ICU and needed oxygen.
Nepal Health Research Council has been carrying out trial research of the anti-viral medicine. Dr Sumit Pandey is the coordinator of the research.
A sum of Rs 25,000 to 35,000 will be spent on using the medicine to treat patients. Dr Bishwokarma said that plasma therapy would also be administered on the patient today.
As many as 20 COVID infected are being treated in the hospital.
Feature Image: File
A version of this article appears in e-paper on September 3, 2020, of The Himalayan Times.